Page 132 - Read Online
P. 132

Carr et al. Vessel Plus 2020;4:12  I  http://dx.doi.org/10.20517/2574-1209.2020.01                                                      Page 13 of 21


                        -47%  -47%  14%  -42%  -42%  -31%  -42%  25%  -53%  -42%  6%  -28%  -28%  17%  17%  -6%  -28%  17%  -36%  -3%  8%  -58%  8%  -3%  -3%  -3%  8%  8%  -25%  -14%  8%  8%  -3%  8%  8%  -3%  -36%
                      Δb

                      Δa  -8%  -8%  25%  -25%  -25%  -25%  -25%  25%  -25%  -25%  17%  17%  -33%  17%  17%  -33%  17%  17%  8%  8%  8%  -42%  8%  8%  8%  8%  8%  8%  8%  -42%  8%  8%  8%  8%  8%  8%  8%


                        42%  42%
                      %      25%  25%  25%  25%  25%  25%  25%  25%  17%  17%  17%  17%  17%  17%  17%  17%  8%  8%  8%  8%  8%  8%  8%  8%  8%  8%  8%  8%  8%  8%  8%  8%  8%  8%  8%

                    2008-2017  n = 12  5  5  3  3  3  3  3  3  3  3  2  2  2  2  2  2  2  2  1  1  1  1  1  1  1  1  1  1  1  1  1  1  1  1  1  1  1







                      Variable  Left ventricular function  Peripheral arterial disease   Comb. arterial disease  Comb. any MI variable Comb. heart failure variables  Comb. CHF or NYHA  Comb. vessel disease  Comb. graft variables  Body size measurements   Congestive heart failure  Number of diseased vessels  Preoperative IABP use  Immunosuppression  Date or order of surgery   On- vs. off-pump CABG  Prior/recent PCI or PTCA  Intraoperative variables  Postoperative variables





                        Age  Gender  Diabetes  Renal failure  Urgency  Lung disease  Neurologic disease  NYHA class  History of MI  Atrial arrhythmia  Repeat operation  Angina  Number of grafts  Valve disease  Hypertension  Race or ethnicity  Smoking status  Left main disease  Cardiogenic shock


                      Δa  39%  39%  28%  17%  17%  17%  17%  17%  6%  44%  44%  -6%  44%  44%  33%  33%  -28%  22%  -28%  11%  11%  11%  11%  11%  11%  11%  -39%  11%  11%  11%  11%  11%  11%  11%  11%  11%  11%


                      %  89%  89%  78%  67%  67%  67%  67%  67%  56%  44%  44%  44%  44%  44%  33%  33%  22%  22%  22%  11%  11%  11%  11%  11%  11%  11%  11%  11%  11%  11%  11%  11%  11%  11%  11%  11%  11%
                      n = 9  8  8  7  6  6  6  6  6  5  4  4  4  4  4  3  3  2  2  2  1  1  1  1  1  1  1  1  1  1  1  1  1  1  1  1  1  1


                    1998-2007



                      Variable  Left ventricular function Comb. heart failure variables  Congestive heart failure  Comb. arterial disease  Comb. CHF or NYHA  Peripheral arterial disease   Body size measurements   Postoperative variables  Comb. graft variables  Hypercholesterolemia  Comb. vessel disease  Date or order of surgery   Aortic cross-clamp duration  Digoxin or digitalis use  Left ventricular hypertrophy  Intraoperative variables  Preoperative diuretic use  Ventri






                        Age    Diabetes  Renal failure  Lung disease  Neurologic disease  Smoking status  Type of graft(s)  Left main disease  Gender  Urgency  Repeat operation  Number of grafts  Valve disease  Hypertension  Heart rate  Functional state  Calcified aorta  Comb. HTN or BP
                 Table 4. Long-term risk model variables by publication year

                      %  50%  50%  50%  50%  50%  50%  50%  50%  50%  50%  50%  50%  50%  50%


                      n = 2  1  1  1  1  1  1  1  1  1  1  1  1  1  1  10














                    ≤ 1997  Variable  Age  Diabetes  Renal failure  Left ventricular function  Neurologic disease  Peripheral arterial disease   Congestive heart failure  Left main disease  Aortic cross-clamp duration  Ventricular wall motion  Comb. arterial disease Comb. heart failure variables  Comb. CHF or NYHA  Comb. vessel disease Total variables (excl. combinations)
   127   128   129   130   131   132   133   134   135   136   137